Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000917:Antibody Formation; D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D002860:Chromium Radioisotopes / Q000737:chemistry; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry; D007371:Interferon-gamma / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000737:chemistry* / Q000627:therapeutic use*; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D002860:Chromium Radioisotopes; D007074:Immunoglobulin G; D010455:Peptides; D007371:Interferon-gamma